The present invention is directed to an amorphous form of cabazitaxel, which can be prepared by dissolving a solid form of cabazitaxel in an organic solvent, and removing the organic solvent to dryness. The amorphous form of cabazitaxel is characterized by DSC as in FIG. 1 and/or X-ray powder diffraction pattern as in FIG. 2.
本发明涉及卡巴嗪的非晶形式,可以通过将卡巴嗪的固态形式溶解在有机溶剂中,然后将有机溶剂蒸发至干燥来制备。卡巴嗪的非晶形式可通过
DSC(差示扫描量热法)如图1和/或X射线粉末衍射图案如图2进行表征。